Geneus Tech announced that it has received funding from GF Xinde Investment Management Co., Ltd, Dian Diagnostics Group Co.,Ltd.
March 01, 2023
Share
Geneus Tech announced that it has received funding on March 2, 2023. The transaction included participation from new investors, GF Xinde Investment Management Co., Ltd and Dian Diagnostics Group Co.,Ltd.
Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The Company's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.
DIAN DIAGNOSTICS GROUP CO.,LTD. 
